MESO logo

Mesoblast Limited (MESO) Depreciation And Amortization

Annual D&A

$4.67 M
+$559.00 K+13.61%

June 30, 2024

Summary

Performance

1-Year Change

+13.61%

3-Year Change

+9.43%

5-Year Change

+118.14%

15-Year Change

+52.63%

MESO Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.54%
MESO annual depreciation & amortization is higher than 62.54% of companies in Healthcare sector

High & Low

All-time High

$4.67 M
MESO annual depreciation & amortization is currently at an all-time high

3-Year Low

$4.11 M
MESO annual depreciation & amortization is currently +13.61% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
MESO previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
MESO next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$63.87 M
MESO annual total expenses is $63.87 million

Annual Operating Expenses

$63.87 M
MESO annual total operating expenses is $63.87 million

Annual Cost Of Goods Sold

-
MESO annual cost of goods sold value is unknown

Annual Interest Expense

$20.66 M
MESO annual interest expense is $20.66 million

Quarterly D&A

$4.67 M
+$2.22 M+90.99%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+403.34%

3-Year Change

+313.29%

5-Year Change

+363.82%

MESO Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.41%
MESO quarterly depreciation & amortization is higher than 77.41% of companies in Healthcare sector

High & Low

All-time High

$4.67 M
MESO quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$927.00 K
MESO quarterly depreciation & amortization is currently +403.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
MESO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MESO next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Total Expenses

-
MESO quarterly total expenses value is unknown

Quarterly Operating Expenses

-
MESO quarterly total operating expenses value is unknown

Quarterly Cost Of Goods Sold

-
MESO quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
MESO quarterly interest expense value is unknown

TTM D&A

$7.11 M
+$2.75 M+63.05%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+73.09%

3-Year Change

+66.72%

5-Year Change

+93.86%

MESO TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.67%
MESO TTM depreciation & amortization is higher than 66.67% of companies in Healthcare sector

High & Low

All-time High

$7.11 M
MESO TTM depreciation & amortization is currently at an all-time high

3-Year Low

$4.11 M
MESO TTM depreciation & amortization is currently +73.09% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
MESO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MESO next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$63.87 M
MESO annual total expenses is $63.87 million

Annual Operating Expenses

$63.87 M
MESO annual total operating expenses is $63.87 million

TTM Cost Of Goods Sold

-
MESO TTM cost of goods sold value is unknown

TTM Interest Expense

-
MESO TTM interest expense value is unknown

MESO Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.6%+403.3%+73.1%
3 y3 years+9.4%+313.3%+66.7%
5 y5 years+118.1%+363.8%+93.9%

MESO Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+13.6%at high+403.3%at high+73.1%
5 y5-yearat high+118.1%at high+403.3%at high+157.9%
alltimeall timeat high>+9999.0%at high+402.8%at high+1519.4%

Mesoblast Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2024
$4.67 M(+13.6%)
$4.67 M(+91.0%)
$7.11 M(+63.1%)
Dec 2023
-
$2.44 M(+163.5%)
$4.36 M(+6.2%)
Jun 2023
$4.11 M(-6.2%)
$927.00 K(-6.4%)
$4.11 M(-3.4%)
Mar 2023
-
$990.00 K(-8.8%)
$4.25 M(-2.8%)
Dec 2022
-
$1.08 M(-1.8%)
$4.38 M(-0.4%)
Sep 2022
-
$1.10 M(+3.2%)
$4.39 M(+0.3%)
Jun 2022
$4.38 M(+2.7%)
$1.07 M(-3.9%)
$4.38 M(-1.3%)
Mar 2022
-
$1.11 M(+1.1%)
$4.44 M(+0.7%)
Dec 2021
-
$1.10 M(+0.8%)
$4.41 M(-17.7%)
Sep 2021
-
$1.09 M(-3.2%)
$5.36 M(+25.6%)
Jun 2021
$4.26 M(+16.3%)
$1.13 M(+4.2%)
$4.26 M(+3.0%)
Mar 2021
-
$1.08 M(-47.2%)
$4.14 M(+3.4%)
Dec 2020
-
$2.05 M(+104.0%)
$4.00 M(+9.2%)
Jun 2020
$3.67 M(+71.4%)
$1.01 M(+6.3%)
$3.67 M(+15.6%)
Mar 2020
-
$946.00 K(-44.8%)
$3.17 M(+15.1%)
Dec 2019
-
$1.72 M(+236.3%)
$2.76 M(+28.8%)
Jun 2019
$2.14 M(-19.3%)
$510.00 K(-4.0%)
$2.14 M(-50.0%)
Mar 2019
-
$531.00 K(-2.4%)
$4.28 M(+70.1%)
Dec 2018
-
$544.00 K(-1.8%)
$2.52 M(-2.2%)
Sep 2018
-
$554.00 K(-79.1%)
$2.57 M(-2.9%)
Jun 2018
$2.65 M
$2.65 M(-315.1%)
$2.65 M(-13.3%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$1.23 M(-305.0%)
$3.06 M(+11.2%)
Dec 2017
-
$601.00 K(-4.8%)
$2.75 M(-5.7%)
Sep 2017
-
$631.00 K(-79.4%)
$2.91 M(-4.7%)
Jun 2017
$3.06 M(+39.5%)
$3.06 M(-298.4%)
$3.06 M(+331.2%)
Mar 2017
-
-$1.54 M(-300.9%)
$709.00 K(-75.2%)
Dec 2016
-
$767.00 K(-0.9%)
$2.85 M(+13.0%)
Sep 2016
-
$774.00 K(+9.2%)
$2.53 M(+15.3%)
Jun 2016
$2.19 M(+36.9%)
$709.00 K(+17.2%)
$2.19 M(+47.8%)
Mar 2016
-
$605.00 K(+37.8%)
$1.48 M(+68.9%)
Dec 2015
-
$439.00 K(0.0%)
$878.00 K(+100.0%)
Sep 2015
-
$439.00 K
$439.00 K
Jun 2015
$1.60 M(+56.3%)
-
-
Jun 2014
$1.02 M(+32.6%)
-
-
Jun 2013
$772.00 K(+103.7%)
-
-
Jun 2012
$379.00 K(+111.9%)
-
-
Jun 2011
$178.90 K(+16.7%)
-
-
Jun 2010
$153.30 K(+28.0%)
-
-
Jun 2009
$119.80 K(-23.6%)
-
-
Jun 2008
$156.80 K(+150.9%)
-
-
Jun 2007
$62.50 K(+43.3%)
-
-
Jun 2006
$43.60 K(+129.5%)
-
-
Jun 2005
$19.00 K
-
-

FAQ

  • What is Mesoblast Limited annual depreciation & amortization?
  • What is the all time high annual D&A for Mesoblast Limited?
  • What is Mesoblast Limited annual D&A year-on-year change?
  • What is Mesoblast Limited quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Mesoblast Limited?
  • What is Mesoblast Limited quarterly D&A year-on-year change?
  • What is Mesoblast Limited TTM depreciation & amortization?
  • What is the all time high TTM D&A for Mesoblast Limited?
  • What is Mesoblast Limited TTM D&A year-on-year change?

What is Mesoblast Limited annual depreciation & amortization?

The current annual D&A of MESO is $4.67 M

What is the all time high annual D&A for Mesoblast Limited?

Mesoblast Limited all-time high annual depreciation & amortization is $4.67 M

What is Mesoblast Limited annual D&A year-on-year change?

Over the past year, MESO annual depreciation & amortization has changed by +$559.00 K (+13.61%)

What is Mesoblast Limited quarterly depreciation & amortization?

The current quarterly D&A of MESO is $4.67 M

What is the all time high quarterly D&A for Mesoblast Limited?

Mesoblast Limited all-time high quarterly depreciation & amortization is $4.67 M

What is Mesoblast Limited quarterly D&A year-on-year change?

Over the past year, MESO quarterly depreciation & amortization has changed by +$3.74 M (+403.34%)

What is Mesoblast Limited TTM depreciation & amortization?

The current TTM D&A of MESO is $7.11 M

What is the all time high TTM D&A for Mesoblast Limited?

Mesoblast Limited all-time high TTM depreciation & amortization is $7.11 M

What is Mesoblast Limited TTM D&A year-on-year change?

Over the past year, MESO TTM depreciation & amortization has changed by +$3.00 M (+73.09%)